Pat Brown, CEO of Impossible Foods (CA, USA) and professor emeritus in the department of biochemistry at Stanford University (CA, USA), takes us through the invention of DNA microarrays, their ...
The hybridization of analytes in a single sample to thousands of different specified targets simultaneously on a microarray has become central to genomics research and is now being applied in the ...
BUFFALO, N.Y. -- A multidisciplinary team of pharmaceutics and computer-science researchers at the University at Buffalo, one of very few teams in the nation applying DNA microarray technology in ...
Based on electrostatic repulsion — in which objects with the same electrical charge repel one another — the technique is relatively simple and inexpensive to implement, and can be carried out in a ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 4 (Jan. 26, 2010), pp. 1482-1487 (6 pages) The use of DNA microarrays to identify nucleotide variation is ...
Phase I and Pharmacologic Study of Oral ZD9331, A Novel Nonpolyglutamated Thymidylate Synthase Inhibitor, in Adult Patients With Solid Tumors ABSTRACT: Aberrant gene expression is critical for tumor ...
The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...
This is a preview. Log in through your library . Abstract Selection of significant genes via expression patterns is important in a microarray problem. Owing to small sample size and large number of ...
Phase I and Pharmacologic Study of Oral ZD9331, A Novel Nonpolyglutamated Thymidylate Synthase Inhibitor, in Adult Patients With Solid Tumors ABSTRACT: Aberrant gene expression is critical for tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback